Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 194,134 | 83,138 | 69,888 | 24,181 | 0 |
| Cost of Goods | 26,846 | 25,333 | 4,833 | 641 | N/A |
| Gross Profit | 167,288 | 57,805 | 65,055 | 23,540 | N/A |
| Operating Expenses | 214,488 | 213,828 | 253,380 | 233,923 | 145,693 |
| Operating Income | -46,354 | -155,690 | -187,492 | -209,742 | -145,693 |
| Other Income | -27,863 | -22,166 | -12,179 | -22,824 | -1,170 |
| Pre-tax Income | -74,217 | -177,856 | -199,671 | -232,566 | -146,863 |
| Income Tax | 593 | 5,245 | -90 | 3 | -1,758 |
| Net Income Continuous | -74,810 | -183,101 | -199,581 | -232,569 | -145,105 |
| Net Income | $-74,810 | $-183,101 | $-199,581 | $-232,569 | $-145,105 |
| EPS Basic Total Ops | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 |
| EPS Basic Continuous Ops | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 |
| EPS Diluted Total Ops | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 |
| EPS Diluted Continuous Ops | -1.61 | -3.99 | -4.39 | -5.58 | -4.11 |
| EPS Diluted Before Non-Recurring Items | -0.97 | -3.12 | -3.40 | -4.65 | -3.37 |
| EBITDA(a) | $-8,854 | $-121,532 | $-169,378 | $-205,654 | $-143,968 |